Pharmacotherapy :
Pharmacotherapy : a pathophysiologic approach /
editors, Joseph T. DiPiro... [et al.]
- 10th ed.
- New York : McGraw-Hill Education, c.2017.
- xxxiii, 2474 p. : 30 cm. ill. (col.) ;
Includes bibliographical references and index.
Section 1: Foundation Issues --
Chapter e1: Health Literacy and Medication Use --
Chapter e2: Cultural Competency --
Chapter e3: Medication Safety Principles and Practices --
Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics --
Chapter e5: Pharmacogenetics --
Chapter e6: Pediatrics --
Chapter e7: Geriatrics --
Chapter e8: Palliative Care --
Chapter e9: Clinical Toxicology --
Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions --
Section 2: Cardiovascular Disorders --
Chapter e11: Cardiovascular Testing --
Chapter 12: Cardiac Arrest --
Chapter 13: Hypertension --
Chapter 14: Chronic Heart Failure --
Chapter 15: Acute Decompensated Heart Failure --
Chapter 16: Stable Ischemic Heart Disease --
Chapter 17: Acute Coronary Syndromes --
Chapter 18: The Arrhythmias --
Chapter 19: Venous Thromboembolism --
Chapter 20: Stroke --
Chapter 21: Dyslipidemia --
Chapter e22: Peripheral Arterial Disease --
Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock --
Chapter 24: Hypovolemic Shock --
Chapter e25: Introduction to Pulmonary Function Testing --
Section 3: Respiratory Disorders --
Chapter 26: Asthma --
Chapter 27: Chronic Obstructive Pulmonary Disease --
Chapter 28: Pulmonary Arterial Hypertension --
Chapter 29: Cystic Fibrosis --
Chapter e30: Drug-Induced Pulmonary Diseases --
Section 4: Gastrointestinal Disorders --
Chapter e31: Evaluation of the Gastrointestinal Tract --
Chapter 32: Gastroesophageal Reflux Disease --
Chapter 33: Peptic Ulcer Disease and Related Disorders --
Chapter 34: Inflammatory Bowel Disease --
Chapter 35: Nausea and Vomiting --
Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome --
Chapter 37: Portal Hypertension and Cirrhosis --
Chapter e38: Drug-Induced Liver Disease --
Chapter 39: Pancreatitis --
Chapter 40: Viral Hepatitis --
Chapter 41: Celiac Disease --
Section 5: Renal Disorders --
Chapter e42: Evaluation of Kidney Function --
Chapter 43: Acute Kidney Injury --
Chapter 44: Chronic Kidney Disease --
Chapter 45: Hemodialysis and Peritoneal Dialysis --
Chapter 46: Drug-Induced Kidney Disease --
Chapter 47: Glomerulonephritis --
Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease --
Chapter 49: Disorders of Sodium and Water Homeostasis --
Chapter 50: Disorders of Calcium and Phosphorus Homeostasis --
Chapter 51: Disorders of Potassium and Magnesium Homeostasis --
Chapter 52: Acid-Base Disorders --
Section 6: Neurologic Disorders --
Chapter e53: Evaluation of Neurologic Illness --
Chapter 54: Alzheimer Disease --
Chapter 55: Multiple Sclerosis --
Chapter 56: Epilepsy --
Chapter 57: Status Epilepticus --
Chapter 58: Acute Management of the Brain Injury Patient --
Chapter 59: Parkinson Disease --
Chapter 60: Pain Management --
Chapter 61: Headache Disorders --
Section 7: Psychiatric Disorders --
Chapter e62: Assessment of Psychiatric Disorders --
Chapter 63: Attention Deficit/Hyperactivity Disorder --
Chapter 64: Eating Disorders --
Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens --
Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine --
Chapter 67: Schizophrenia --
Chapter 68: Major Depressive Disorder --
Chapter 69: Bipolar Disorder --
Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders. Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder --
Chapter 72: Sleep-Wake Disorders --
Chapter 73: Disorders Associated with Intellectual Disabilities --
Section 8: Endocrinologic Disorders --
Chapter 74: Diabetes Mellitus --
Chapter 75: Thyroid Disorders --
Chapter 76: Adrenal Gland Disorders --
Chapter e77: Pituitary Gland Disorders --
Section 9: Gynecologic and Obstetric Disorders --
Chapter 78: Pregnancy and Lactation: Therapeutic Considerations --
Chapter 79: Contraception --
Chapter 80: Menstruation-Related Disorders --
Chapter 81: Endometriosis --
Chapter 82: Hormone Therapy in Women --
Section 10: Urologic Disorders --
Chapter 83: Erectile Dysfunction --
Chapter 84: Benign Prostatic Hyperplasia --
Chapter 85: Urinary Incontinence --
Section 11: Immunologic Disorders --
Chapter e86: Function and Evaluation of the Immune System --
Chapter 87: Systemic Lupus Erythematosus --
Chapter e88: Drug Allergy --
Chapter 89: Solid-Organ Transplantation --
Section 12: Rheumatologic Disorders --
Chapter 90: Osteoarthritis --
Chapter 91: Rheumatoid Arthritis --
Chapter 92: Osteoporosis and Osteomalacia --
Chapter 93: Gout and Hyperuricemia --
Section 13: Ophthalmic and Otolaryngological Disorders --
Chapter 94: Glaucoma --
Chapter 95: Allergic Rhinitis --
Section 14: Dermatologic Disorders --
Chapter 96: Acne Vulgaris --
Chapter 97: Psoriasis --
Chapter 98: Atopic Dermatitis --
Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions --
Section 15: Hematologic Disorders --
Chapter 100: Anemias --
Chapter 101: Coagulation Disorders --
Chapter 102: Sickle Cell Disease --
Chapter e103: Drug-Induced Hematologic Disorders --
Section 16: Infectious Diseases --
Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy --
Chapter 105: Antimicrobial Regimen Selection --
Chapter 106: Central Nervous System Infections --
Chapter 107: Lower Respiratory Tract Infections --
Chapter 108: Upper Respiratory Tract Infections --
Chapter 109: Influenza --
Chapter 110: Skin and Soft-Tissue Infections --
Chapter 111: Infective Endocarditis --
Chapter 112: Tuberculosis --
Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings --
Chapter 114: Intra-Abdominal Infections --
Chapter 116: Urinary Tract Infections and Prostatitis --
Chapter e115: Parasitic Diseases --
Chapter 117: Sexually Transmitted Diseases --
Chapter 118: Bone and Joint Infections --
Chapter 119: Sepsis and Septic Shock --
Chapter 120: Superficial Fungal Infections --
Chapter 121: Invasive Fungal Infections --
Chapter 122: Infections in Immunocompromised Patients --
Chapter 123: Antimicrobial Prophylaxis in Surgery --
Chapter e124: Travel Health --
Chapter 125: Vaccines and Immunoglobulins --
Chapter 126: Human Immunodeficiency Virus Infection --
Section 17: Oncologic Disorders --
Chapter 127: Cancer Treatment and Chemotherapy --
Chapter 128: Breast Cancer --
Chapter 129: Lung Cancer --
Chapter 130: Colorectal Cancer --
Chapter 131: Prostate Cancer --
Chapter 132: Lymphomas --
Chapter 133: Ovarian Cancer --
Chapter 134: Acute Leukemias --
Chapter 135: Chronic Leukemias --
Chapter 136: Multiple Myeloma --
Chapter e137: Myelodysplastic Syndromes --
Chapter e138: Renal Cell Carcinoma --
Chapter 139: Melanoma --
Chapter 140: Hematopoietic Stem Cell Transplantation --
Section 18: Nutritional Disorders --
Chapter 141: Assessment of Nutrition Status and Nutrition Requirements --
Chapter 142: Parenteral Nutrition --
Chapter 143: Enteral Nutrition --
Chapter 144: Obesity.
Focuses on how to achieve optimal patient outcomes through evidence-based medication therapy. This book is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles.
9781259587481 (hardcover) 1259587487
2016035246
Drug Therapy.
Chemotherapy.
--Text book
615.58 / PHA
Includes bibliographical references and index.
Section 1: Foundation Issues --
Chapter e1: Health Literacy and Medication Use --
Chapter e2: Cultural Competency --
Chapter e3: Medication Safety Principles and Practices --
Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics --
Chapter e5: Pharmacogenetics --
Chapter e6: Pediatrics --
Chapter e7: Geriatrics --
Chapter e8: Palliative Care --
Chapter e9: Clinical Toxicology --
Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions --
Section 2: Cardiovascular Disorders --
Chapter e11: Cardiovascular Testing --
Chapter 12: Cardiac Arrest --
Chapter 13: Hypertension --
Chapter 14: Chronic Heart Failure --
Chapter 15: Acute Decompensated Heart Failure --
Chapter 16: Stable Ischemic Heart Disease --
Chapter 17: Acute Coronary Syndromes --
Chapter 18: The Arrhythmias --
Chapter 19: Venous Thromboembolism --
Chapter 20: Stroke --
Chapter 21: Dyslipidemia --
Chapter e22: Peripheral Arterial Disease --
Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock --
Chapter 24: Hypovolemic Shock --
Chapter e25: Introduction to Pulmonary Function Testing --
Section 3: Respiratory Disorders --
Chapter 26: Asthma --
Chapter 27: Chronic Obstructive Pulmonary Disease --
Chapter 28: Pulmonary Arterial Hypertension --
Chapter 29: Cystic Fibrosis --
Chapter e30: Drug-Induced Pulmonary Diseases --
Section 4: Gastrointestinal Disorders --
Chapter e31: Evaluation of the Gastrointestinal Tract --
Chapter 32: Gastroesophageal Reflux Disease --
Chapter 33: Peptic Ulcer Disease and Related Disorders --
Chapter 34: Inflammatory Bowel Disease --
Chapter 35: Nausea and Vomiting --
Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome --
Chapter 37: Portal Hypertension and Cirrhosis --
Chapter e38: Drug-Induced Liver Disease --
Chapter 39: Pancreatitis --
Chapter 40: Viral Hepatitis --
Chapter 41: Celiac Disease --
Section 5: Renal Disorders --
Chapter e42: Evaluation of Kidney Function --
Chapter 43: Acute Kidney Injury --
Chapter 44: Chronic Kidney Disease --
Chapter 45: Hemodialysis and Peritoneal Dialysis --
Chapter 46: Drug-Induced Kidney Disease --
Chapter 47: Glomerulonephritis --
Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease --
Chapter 49: Disorders of Sodium and Water Homeostasis --
Chapter 50: Disorders of Calcium and Phosphorus Homeostasis --
Chapter 51: Disorders of Potassium and Magnesium Homeostasis --
Chapter 52: Acid-Base Disorders --
Section 6: Neurologic Disorders --
Chapter e53: Evaluation of Neurologic Illness --
Chapter 54: Alzheimer Disease --
Chapter 55: Multiple Sclerosis --
Chapter 56: Epilepsy --
Chapter 57: Status Epilepticus --
Chapter 58: Acute Management of the Brain Injury Patient --
Chapter 59: Parkinson Disease --
Chapter 60: Pain Management --
Chapter 61: Headache Disorders --
Section 7: Psychiatric Disorders --
Chapter e62: Assessment of Psychiatric Disorders --
Chapter 63: Attention Deficit/Hyperactivity Disorder --
Chapter 64: Eating Disorders --
Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens --
Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine --
Chapter 67: Schizophrenia --
Chapter 68: Major Depressive Disorder --
Chapter 69: Bipolar Disorder --
Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders. Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder --
Chapter 72: Sleep-Wake Disorders --
Chapter 73: Disorders Associated with Intellectual Disabilities --
Section 8: Endocrinologic Disorders --
Chapter 74: Diabetes Mellitus --
Chapter 75: Thyroid Disorders --
Chapter 76: Adrenal Gland Disorders --
Chapter e77: Pituitary Gland Disorders --
Section 9: Gynecologic and Obstetric Disorders --
Chapter 78: Pregnancy and Lactation: Therapeutic Considerations --
Chapter 79: Contraception --
Chapter 80: Menstruation-Related Disorders --
Chapter 81: Endometriosis --
Chapter 82: Hormone Therapy in Women --
Section 10: Urologic Disorders --
Chapter 83: Erectile Dysfunction --
Chapter 84: Benign Prostatic Hyperplasia --
Chapter 85: Urinary Incontinence --
Section 11: Immunologic Disorders --
Chapter e86: Function and Evaluation of the Immune System --
Chapter 87: Systemic Lupus Erythematosus --
Chapter e88: Drug Allergy --
Chapter 89: Solid-Organ Transplantation --
Section 12: Rheumatologic Disorders --
Chapter 90: Osteoarthritis --
Chapter 91: Rheumatoid Arthritis --
Chapter 92: Osteoporosis and Osteomalacia --
Chapter 93: Gout and Hyperuricemia --
Section 13: Ophthalmic and Otolaryngological Disorders --
Chapter 94: Glaucoma --
Chapter 95: Allergic Rhinitis --
Section 14: Dermatologic Disorders --
Chapter 96: Acne Vulgaris --
Chapter 97: Psoriasis --
Chapter 98: Atopic Dermatitis --
Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions --
Section 15: Hematologic Disorders --
Chapter 100: Anemias --
Chapter 101: Coagulation Disorders --
Chapter 102: Sickle Cell Disease --
Chapter e103: Drug-Induced Hematologic Disorders --
Section 16: Infectious Diseases --
Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy --
Chapter 105: Antimicrobial Regimen Selection --
Chapter 106: Central Nervous System Infections --
Chapter 107: Lower Respiratory Tract Infections --
Chapter 108: Upper Respiratory Tract Infections --
Chapter 109: Influenza --
Chapter 110: Skin and Soft-Tissue Infections --
Chapter 111: Infective Endocarditis --
Chapter 112: Tuberculosis --
Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings --
Chapter 114: Intra-Abdominal Infections --
Chapter 116: Urinary Tract Infections and Prostatitis --
Chapter e115: Parasitic Diseases --
Chapter 117: Sexually Transmitted Diseases --
Chapter 118: Bone and Joint Infections --
Chapter 119: Sepsis and Septic Shock --
Chapter 120: Superficial Fungal Infections --
Chapter 121: Invasive Fungal Infections --
Chapter 122: Infections in Immunocompromised Patients --
Chapter 123: Antimicrobial Prophylaxis in Surgery --
Chapter e124: Travel Health --
Chapter 125: Vaccines and Immunoglobulins --
Chapter 126: Human Immunodeficiency Virus Infection --
Section 17: Oncologic Disorders --
Chapter 127: Cancer Treatment and Chemotherapy --
Chapter 128: Breast Cancer --
Chapter 129: Lung Cancer --
Chapter 130: Colorectal Cancer --
Chapter 131: Prostate Cancer --
Chapter 132: Lymphomas --
Chapter 133: Ovarian Cancer --
Chapter 134: Acute Leukemias --
Chapter 135: Chronic Leukemias --
Chapter 136: Multiple Myeloma --
Chapter e137: Myelodysplastic Syndromes --
Chapter e138: Renal Cell Carcinoma --
Chapter 139: Melanoma --
Chapter 140: Hematopoietic Stem Cell Transplantation --
Section 18: Nutritional Disorders --
Chapter 141: Assessment of Nutrition Status and Nutrition Requirements --
Chapter 142: Parenteral Nutrition --
Chapter 143: Enteral Nutrition --
Chapter 144: Obesity.
Focuses on how to achieve optimal patient outcomes through evidence-based medication therapy. This book is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles.
9781259587481 (hardcover) 1259587487
2016035246
Drug Therapy.
Chemotherapy.
--Text book
615.58 / PHA